This miRNA, which was upregulated in the CBX group, has been described as a biomarker for detecting lymph node metastasis in stage III colorectal carcinoma (Xu et al., 2014), as well as an early-stage breast cancer biomarker in serum (Shimomura et al., 2016). This evidence concerns the gene CBX1 and breast carcinoma.